Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Esophagogastric Adenocarcinoma”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Looking for participantsNCT07026149
What this trial is testing

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 30
Not applicableLooking for participantsNCT06649474
What this trial is testing

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

Who this might be right for
Pancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinoma+3 more
University Hospital, Clermont-Ferrand 100
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05505461
What this trial is testing

Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Adenocarcinoma of Esophagogastric Junction
Peking University People's Hospital 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06681298
What this trial is testing

A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab

Who this might be right for
Adenocarcinoma of the Esophagogastric JunctionPerioperative Period
xiaohua li 36
Large-scale testing (Phase 3)Active Not RecruitingNCT01924819
What this trial is testing

Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Australasian Gastro-Intestinal Trials Group 574
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507968
What this trial is testing

TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 101
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Large-scale testing (Phase 3)Study completedNCT02661971
What this trial is testing

FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)

Who this might be right for
Stomach CancerGastroesophageal Junction Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 180
Large-scale testing (Phase 3)UnknownNCT04393584
What this trial is testing

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsGastrointestinal NeoplasmsDocetaxel+3 more
Blokhin's Russian Cancer Research Center 538
Testing effectiveness (Phase 2)Looking for participantsNCT06766305
What this trial is testing

QL1706 Combined With SOX Used in Theperioperative Treatment

Who this might be right for
Gastric CancersEsophagogastric Junction Cancers
Xiangdong Cheng 54
Early research (Phase 1)Looking for participantsNCT07059299
What this trial is testing

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric AdenocarcinomaEsophageal Adenocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT07161453
What this trial is testing

Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 500
Large-scale testing (Phase 3)Study completedNCT01962246
What this trial is testing

Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Hebei Medical University 169
Testing effectiveness (Phase 2)Looking for participantsNCT06123338
What this trial is testing

Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric AdenocarcinomaHER2 Gene Mutation
Memorial Sloan Kettering Cancer Center 49
Post-approval studies (Phase 4)Not Yet RecruitingNCT07149181
What this trial is testing

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 1,000
Testing effectiveness (Phase 2)Study completedNCT02287129
What this trial is testing

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Technical University of Munich 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07053332
What this trial is testing

A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma

Who this might be right for
Esophagogastric Junction/Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital 20
Not applicableUnknownNCT04269083
What this trial is testing

A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction

Who this might be right for
Esophageal Cancer
Azienda Ospedaliera Universitaria Integrata Verona 128
Post-approval studies (Phase 4)Not Yet RecruitingNCT07132528
What this trial is testing

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 1,000
Load More Results